NC
Nicholas Company’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $125K | Sell |
825
-68,621
| -99% | -$10.4M | ﹤0.01% | 216 |
|
2025
Q1 | $10.5M | Hold |
69,446
| – | – | 0.18% | 117 |
|
2024
Q4 | $12.8M | Hold |
69,446
| – | – | 0.21% | 109 |
|
2024
Q3 | $13.7M | Sell |
69,446
-1,235
| -2% | -$243K | 0.22% | 106 |
|
2024
Q2 | $14.6M | Hold |
70,681
| – | – | 0.24% | 104 |
|
2024
Q1 | $19.2M | Hold |
70,681
| – | – | 0.32% | 91 |
|
2023
Q4 | $16.7M | Buy |
70,681
+10,695
| +18% | +$2.53M | 0.3% | 94 |
|
2023
Q3 | $11.8M | Hold |
59,986
| – | – | 0.24% | 101 |
|
2023
Q2 | $12.6M | Hold |
59,986
| – | – | 0.24% | 100 |
|
2023
Q1 | $12.1M | Buy |
59,986
+10,275
| +21% | +$2.07M | 0.25% | 103 |
|
2022
Q4 | $10.8M | Sell |
49,711
-1,040
| -2% | -$227K | 0.23% | 106 |
|
2022
Q3 | $9.99M | Hold |
50,751
| – | – | 0.23% | 107 |
|
2022
Q2 | $10.9M | Sell |
50,751
-25
| -0% | -$5.35K | 0.24% | 104 |
|
2022
Q1 | $14.4M | Sell |
50,776
-904
| -2% | -$257K | 0.26% | 103 |
|
2021
Q4 | $19.5M | Sell |
51,680
-15
| -0% | -$5.65K | 0.32% | 87 |
|
2021
Q3 | $21.3M | Sell |
51,695
-8,860
| -15% | -$3.66M | 0.38% | 73 |
|
2021
Q2 | $22.4M | Hold |
60,555
| – | – | 0.39% | 71 |
|
2021
Q1 | $17.6M | Sell |
60,555
-495
| -0.8% | -$143K | 0.33% | 85 |
|
2020
Q4 | $15.3M | Buy |
61,050
+65
| +0.1% | +$16.2K | 0.29% | 99 |
|
2020
Q3 | $13.8M | Buy |
+60,985
| New | +$13.8M | 0.29% | 98 |
|